Massmedica Statistics

Total Valuation

Massmedica has a market cap or net worth of PLN 9.56 million. The enterprise value is 14.90 million.

Market Cap	9.56M
Enterprise Value	14.90M

Important Dates

The next estimated earnings date is Monday, August 11, 2025.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Massmedica has 2.41 million shares outstanding.

Current Share Class	2.41M
Shares Outstanding	2.41M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	78.83%
Owned by Institutions (%)	n/a
Float	278,159

Valuation Ratios

The trailing PE ratio is 15.28.

PE Ratio	15.28
Forward PE	n/a
PS Ratio	0.29
PB Ratio	1.78
P/TBV Ratio	1.79
P/FCF Ratio	n/a
P/OCF Ratio	5.93
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.98, with an EV/FCF ratio of -116.47.

EV / Earnings	23.80
EV / Sales	0.46
EV / EBITDA	7.98
EV / EBIT	11.22
EV / FCF	-116.47

Financial Position

The company has a current ratio of 1.54, with a Debt / Equity ratio of 1.02.

Current Ratio	1.54
Quick Ratio	0.34
Debt / Equity	1.02
Debt / EBITDA	2.94
Debt / FCF	-42.87
Interest Coverage	3.21

Financial Efficiency

Return on equity (ROE) is 12.35% and return on invested capital (ROIC) is 8.13%.

Return on Equity (ROE)	12.35%
Return on Assets (ROA)	4.19%
Return on Invested Capital (ROIC)	8.13%
Return on Capital Employed (ROCE)	14.64%
Revenue Per Employee	1.92M
Profits Per Employee	36,816
Employee Count	17
Asset Turnover	1.65
Inventory Turnover	1.67

Taxes

In the past 12 months, Massmedica has paid 237,342 in taxes.

Income Tax	237,342
Effective Tax Rate	27.50%

Stock Price Statistics

The stock price has increased by +1.53% in the last 52 weeks. The beta is 0.48, so Massmedica's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	+1.53%
50-Day Moving Average	4.33
200-Day Moving Average	5.29
Relative Strength Index (RSI)	42.22
Average Volume (20 Days)	2,702

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Massmedica had revenue of PLN 32.61 million and earned 625,876 in profits. Earnings per share was 0.26.

Revenue	32.61M
Gross Profit	12.48M
Operating Income	1.33M
Pretax Income	863,218
Net Income	625,876
EBITDA	1.87M
EBIT	1.33M
Earnings Per Share (EPS)	0.26

Full Income Statement

Balance Sheet

The company has 149,378 in cash and 5.48 million in debt, giving a net cash position of -5.33 million or -2.21 per share.

Cash & Cash Equivalents	149,378
Total Debt	5.48M
Net Cash	-5.33M
Net Cash Per Share	-2.21
Equity (Book Value)	5.38M
Book Value Per Share	2.23
Working Capital	6.20M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.61 million and capital expenditures -1.74 million, giving a free cash flow of -127,901.

Operating Cash Flow	1.61M
Capital Expenditures	-1.74M
Free Cash Flow	-127,901
FCF Per Share	-0.05

Full Cash Flow Statement

Margins

Gross margin is 38.28%, with operating and profit margins of 4.07% and 1.92%.

Gross Margin	38.28%
Operating Margin	4.07%
Pretax Margin	2.65%
Profit Margin	1.92%
EBITDA Margin	5.72%
EBIT Margin	4.07%
FCF Margin	n/a

Dividends & Yields

Massmedica does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	6.54%
FCF Yield	-1.34%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Massmedica has an Altman Z-Score of 2.62 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.62
Piotroski F-Score	6